from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3732/-

LFCtreatmentdescriptionclass of inhibitor

-1.268

Amikacinug/mL Amikacintranslation

-0.940

Cap5-10ug/mL Capreomycintranslation

-1.517

Rox10-50 ug/mL Roxithromycintranslation

0.058

SM2-5 ug/mL Streptomycintranslation

0.664

Tet5-10 ug/mL Tetracyclinetranslation

-1.092

Rif0.2-5ug/mL Rifampicintranscription

-0.807

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.219

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.059

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.348

CPZ10-50 ug/mL Chlorpromazinerespiration

0.390

Clofazimine10-13 ug/mL Clofaziminerespiration

0.116

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-3.333

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.637

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.808

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.303

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.020

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.227

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.272

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.628

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.631

KCN5-20 ug/mL Potassium cyaniderespiration

1.016

NaN30.2-2 mM Sodium aziderespiration

0.350

Nigericin50 uM Nigericinrespiration

-1.112

TRC10-150 ug/mL Triclosanrespiration

0.090

TRZ10-25 ug/mL Thioridazinerespiration

-1.972

Valinomycin0.5-10 uM Valinomycinrespiration

3.478

ZnSO42 mM ZnSO4respiration

0.929

menadione6-10 ug/mL Menadionerespiration

0.011

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.022

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.470

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.486

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.820

NRP_1Non-replicating persistence stage 1dosRassociated

0.357

Amp0.2mg/mL AmpicillincellWall

-0.005

Cephalexin20-100 ug/mL CephalexincellWall

-0.278

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.583

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.523

EMB10-20 ug/mL EthambutolcellWall

-0.282

Eta12-40 ug/mL EthionamidecellWall

-0.894

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.376

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.082

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.068

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.307

BZA0.12 mg/mL BenzamidearomaticAmides

0.400

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.613

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.253

H2O24 mM hydrogen peroxideDNAdamaging

-0.372

Levo10 ug/mL LevofloxacinDNAdamaging

0.188

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.209

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.063

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.097

UVUV-irradiationDNAdamaging

1.114

ARP41-4 ug/mL Antitubercular compound ARP4?

0.276

Antimycin12.5-50 ug/mL Antimycin A?

0.233

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.063

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.026

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.220

PA8240.2-2 ug/mL PA-824?

-0.288

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.083

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.252

Verapamil50 uM Verapamil?

-0.312

mercaptoethanol2 mM 2-Mercaptoethanol?

0.892

methoxatin10-20 ug/mL Methoxatin?